Theratechnologies Inc T.TH

How long must we wait

[Garp1]

IMO, Paul was forced to come out with this announcement because of the new brokerage firm reports and the fact that he had told the market that news was coming in December. I believe He would of continued to hide the facts,if the brokerage firms had not produced any report. I also think that has a CEO and based on the information he told the markets he should have refrained form pursuing or even suggesting a revised trial plan whithout at least demonstrating the viability of such an option. A post-mortum analysis should have been proposed by Paul before even suggesting any continuance of the trial and he should have implemented all necessary cost cutting measures and strategic decisions to demonstrate is committement to protect the business, the shareholder  and also indicated to the market that he was taking all measures required to recover and grow from this. This should have been done at the same time as the announcement. One must question at this stage if Paul represents the type of CEO that Thera needs right now.

[palinc2000]

You are suggesting that they should have delayed making an announcement until Plan B had been clearly elanorated....That would have been unfair to patients and unethical....I think patients interest must be prioritized over shareholders interest Of course THTX will have to convince the market that they have a viable plan and the sooner the better but not at the expense of depth and well thought

[smallcapinv]

There is such a thing called material information that requires public disclosure.  Otherwise might as well not be publically traded. 

[jfm1330]

Again, the opacity of this management is a big problem. They said in the press release that "efficacy results seen thus far were not convincing enough to pursue enrolling patients and did not outweigh the adverse events see in some patients". So if what they said is true, there was some efficacy results, just not good enough, but we have no idea what these results are and how many

[smallcapinv]

Occular side effects are serious and should be first thing that is checked. This is enough to kill the program permanently. In fact it may already be dead but they have not provided clarity. 

[jfm1330]

You don't know what you talk about. Occular toxicity is very common with anti-cancer drugs and most are manageable.

[smallcapinv]

Time will tell who is correct. At least I am keeping my comment respectful. 

[Garp1]

Again, it’s not by throwing away money against the wind and hoping for a miracle that a company survives, but trough a clear-cut strategy that protect the business and shareholders wealth in order to survive and thrive in the future. Paul laid out clearly that the trial up to now is a failure in terms of efficacy and safety. He laid out a fuzzy plan for the future without any underlying support